Literature DB >> 27739323

Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.

Yaxia Yuan1, Xiaoqin Huang1, Jun Zhu2, Chang-Guo Zhan1.   

Abstract

This is a brief review of computational modeling studies on the detailed structures and mechanism of human dopamine transporter (hDAT), as well as its interaction with HIV-1 transactivator of transcription (Tat). Extensive molecular modeling, docking and dynamics simulations have resulted in reasonable structural models of hDAT in three typical conformational states, its dopamine uptake mechanism and its interaction with Tat. The obtained hDAT models in different conformational states and their complexes with dopamine and Tat have provided novel structural and mechanistic insights concerning how hDAT uptakes dopamine and how Tat affects the dopamine uptake by hDAT. The computational insights, that are consistent with available experimental data, should be valuable for future rational design of novel therapeutic strategies for treatment of HIV-associated neurocognitive disorders.

Entities:  

Keywords:  HIV virus; drug abuse; drug design; neurocognitive disorder; protein–protein interaction; transporter

Year:  2016        PMID: 27739323      PMCID: PMC6113701          DOI: 10.4155/fmc-2016-0138

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  72 in total

1.  Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

Authors:  Mark Froimowitz; Yonghong Gu; Les A Dakin; Pamela M Nagafuji; Charles J Kelley; Damon Parrish; Jeffrey R Deschamps; Aaron Janowsky
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

2.  Identification of a chloride ion binding site in Na+/Cl -dependent transporters.

Authors:  Lucy R Forrest; Sotiria Tavoulari; Yuan-Wei Zhang; Gary Rudnick; Barry Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

3.  Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

Authors:  L Hudson; J Liu; A Nath; M Jones; R Raghavan; O Narayan; D Male; I Everall
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

Review 4.  The use of LeuT as a model in elucidating binding sites for substrates and inhibitors in neurotransmitter transporters.

Authors:  Claus J Loland
Journal:  Biochim Biophys Acta       Date:  2014-04-24

5.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

6.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

7.  Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.

Authors:  Nianhang Chen; Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

8.  Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Authors:  Rejwi Acharya Dahal; Akula Bala Pramod; Babita Sharma; Danielle Krout; James D Foster; Joo Hwan Cha; Jianjing Cao; Amy Hauck Newman; John R Lever; Roxanne A Vaughan; L Keith Henry
Journal:  J Biol Chem       Date:  2014-08-31       Impact factor: 5.157

9.  HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.

Authors:  Jun Zhu; Charles F Mactutus; David R Wallace; Rosemarie M Booze
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

10.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

View more
  11 in total

1.  Flipped Phenyl Ring Orientations of Dopamine Binding with Human and Drosophila Dopamine Transporters: Remarkable Role of Three Nonconserved Residues.

Authors:  Yaxia Yuan; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2018-03-09       Impact factor: 4.418

2.  Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties.

Authors:  Xiabin Chen; Jing Deng; Wenpeng Cui; Shurong Hou; Jinling Zhang; Xirong Zheng; Xin Ding; Huimei Wei; Ziyuan Zhou; Kyungbo Kim; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2018-03-19       Impact factor: 4.009

3.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

4.  Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse.

Authors:  Fang Zheng; Xiabin Chen; Kyungbo Kim; Ting Zhang; Haifeng Huang; Shuo Zhou; Jinling Zhang; Zhenyu Jin; Chang-Guo Zhan
Journal:  AAPS J       Date:  2020-03-18       Impact factor: 4.009

Review 5.  The role of human dopamine transporter in NeuroAIDS.

Authors:  Jun Zhu; Subramaniam Ananthan; Chang-Guo Zhan
Journal:  Pharmacol Ther       Date:  2017-10-05       Impact factor: 12.310

6.  Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.

Authors:  Charles Adeniran; Yaxia Yuan; Sarah E Davis; Ciai Lin; Jiahui Xu; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2021-04-22       Impact factor: 4.418

7.  Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.

Authors:  Wei-Lun Sun; Pamela M Quizon; Yaxia Yuan; Wei Zhang; Subramaniam Ananthan; Chang-Guo Zhan; Jun Zhu
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

8.  Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport.

Authors:  Wei-Lun Sun; Pamela M Quizon; Yaxia Yuan; Matthew J Strauss; Richard McCain; Chang-Guo Zhan; Jun Zhu
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

9.  Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.

Authors:  Ting Zhang; Huimei Wei; Jing Deng; Fang Zheng; Chang-Guo Zhan
Journal:  Neuropharmacology       Date:  2020-07-22       Impact factor: 5.250

10.  Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.

Authors:  Pamela M Quizon; Yaxia Yuan; Yike Zhu; Yi Zhou; Matthew J Strauss; Wei-Lun Sun; Chang-Guo Zhan; Jun Zhu
Journal:  J Neuroimmune Pharmacol       Date:  2021-02-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.